Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Head-To-Head Spine Fracture PMMA Trials Urged By FDA Guidance

This article was originally published in The Gray Sheet

Executive Summary

Two-year follow-up of patients in concurrent, randomized, controlled studies of PMMA-based bone cements for spinal insufficiency fractures is recommended by FDA to support 510(k) submissions

You may also be interested in...



BlueCross TEC Critiques Kyphoplasty; Kyphon Trial To Address Concerns

Kyphon is conducting a large, multi-center trial in response to concerns about the lack of controls in kyphoplasty trials to date, reflected most recently in a pair of BlueCross BlueShield Association Technology Evaluation Center assessments

BlueCross TEC Critiques Kyphoplasty; Kyphon Trial To Address Concerns

Kyphon is conducting a large, multi-center trial in response to concerns about the lack of controls in kyphoplasty trials to date, reflected most recently in a pair of BlueCross BlueShield Association Technology Evaluation Center assessments

Kyphoplasty Bone Cement Clearance Rounds Out Kyphon Line

Kyphon will market its kyphoplasty technology for fixation of osteoporosis-related vertebral compression fractures to referring physicians following recent approval of KyphX HV-R bone cement

Related Content

UsernamePublicRestriction

Register

MT021212

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel